It stimulates new bone formation
Full AI Image Prompt: Create a clinical safety infographic titled GHK-Cu Safety Considerations by Route. Use a three-column matrix labeled Topical products, Wound-care study context, and Injectable or compounded preparations. Under topical products, include skin irritation, allergic reaction, and formulation sensitivity. Under wound-care study context, include study exclusions, copper or peptide sensitivity, and dressings or adhesives. Under injectable or compounded preparations, include limited human safety data, peptide-related impurities, aggregation risk, and immunogenicity risk. Use a calm medical style, white background, simple icons, and subtle copper-blue accents
If a package is lost, held, damaged or wrong, our delivery guarantee reships or refunds it, no dispute needed
A peptide vial handled incorrectly at this stage compromises shelf life regardless of how well it was stored before
Projected approval path: If Phase III trials confirm safety and effectiveness, Cagrilintide will likely be submitted for regulatory approval as a prescription obesity treatment in the next few years
Dry, dehydrated, mature or barrier-stressed skin